BeOne Medicines Ltd. (HKG:6160)
159.60
+7.10 (4.66%)
Jul 15, 2025, 10:44 AM HKT
BeOne Medicines Employees
BeOne Medicines had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
2.95M HKD
Profits / Employee
-277.52K HKD
Market Cap
234.45B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11,000 | 400 | 3.77% |
Dec 31, 2023 | 10,600 | 1,600 | 17.78% |
Dec 31, 2022 | 9,000 | 1,000 | 12.50% |
Dec 31, 2021 | 8,000 | 2,700 | 50.94% |
Dec 31, 2020 | 5,300 | 1,800 | 51.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Hansoh Pharmaceutical Group Company | 8,989 |
Innovent Biologics | 5,659 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Sino Biopharmaceutical | 24,379 |
Akeso | 3,035 |
CSPC Pharmaceutical Group | 21,400 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
BeOne Medicines News
- 20 days ago - Glenmark Pharmaceuticals launches TEVIMBRA in India for advanced lung and esophageal cancer treatment - Business Upturn
- 5 weeks ago - Glenmark Pharmaceuticals to launch Zanubrutinib (BRUKINSA) in India after DCGI approval - Business Upturn
- 5 weeks ago - Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple - Investor's Business Daily
- 6 weeks ago - BeiGene gets EU backing for neck and head cancer treatment - Seeking Alpha
- 2 months ago - Market Shrugs Off This Drugmaker's Turnaround - Benzinga
- 2 months ago - Earnings Preview: BeiGene - Benzinga
- 2 months ago - Undercovered Dozen: Richtech Robotics, Intesa Sanpaolo, BeiGene, Analog Devices + - Seeking Alpha
- 2 months ago - BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit - Seeking Alpha